Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;39(10):1028-1037.
doi: 10.1016/j.healun.2020.07.008. Epub 2020 Jul 24.

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics

Affiliations
Review

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics

Tajinder P Singh et al. J Heart Lung Transplant. 2020 Oct.
No abstract available

Keywords: heart transplantation; organ donor; outcomes; pediatric; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Median donor (a) age by year and geographic location (transplants: from January 1995 to June 2018) and (b) BMI by year and geographic location (transplants: from January 1992 to June 2018). BMI, body mass index.
Figure 2
Figure 2
Donor cause of death by location and era (transplants: January 1992—June 2018). CVA, cerebrovascular accident.
Figure 3
Figure 3
Percentage of donors with a history of (a) smoking (transplants: from January 1995 to June 2018) and (b) alcohol (transplants: from January 2005 to June 2018) for recipients aged 11–17 years and donors aged ≥11 years by year.
Figure 4
Figure 4
Percentage of donors with a history of (a) cocaine use (transplants: January 2000—June 2018) and (b) other drug use (transplants: January 2000—June 2018) for recipients aged 11–17 years and donors aged ≥11 years by year.
Figure 5
Figure 5
Percentage of donors with LVEF <50% by year (transplants: January 2005—June 2018). LVEF, left ventricular ejection fraction.
Figure 6
Figure 6
Kaplan—Meier survival within 12 months by donor age and location (transplants: January 2000—June 2017). NS, non-significant.
Figure 7
Figure 7
Kaplan—Meier survival within 12 months by donor and recipient age (transplants: January 2000—June 2017).
Figure 8
Figure 8
Kaplan—Meier survival within 12 months by (a) donor cause of death (transplants: January 2000—June 2017) and (b) donor LVEF (transplants: January 2005—June 2017). CVA, cerebrovascular accident; LVEF, left ventricular ejection fraction; NS, non-significant.
Figure 9
Figure 9
Kaplan—Meier survival within 12 months by donor age and ischemic time (transplants: January 2000—June 2017).
Figure 10
Figure 10
Kaplan—Meier survival within 12 months by LVEF and ischemic time (transplants: January 2000—June 2017). hrs, hours; LVEF, left ventricular ejection fraction.
Figure 11
Figure 11
Kaplan—Meier survival within 5 years conditional on survival to 1 year, by donor age and location (transplants: January 2000—June 2013). NS, non-significant.
Figure 12
Figure 12
Kaplan–Meier survival within 5 years conditional on survival to 1 year for recipients aged 11–17 years and donors aged ≥11 years by donor history of (a) smoking (transplants: January 2000—June 2013) and (b) alcohol use (transplants: January 2005—June 2013). NS, non-significant.
Figure 13
Figure 13
Kaplan—Meier survival within 5 years conditional on survival to 1 year for recipients aged 11–17 years and donors aged ≥11 years by donor history of (a) cocaine use (transplants: January 2000—June 2013) and (b) other drug use (transplants: January 2000—June 2013).
Figure 14
Figure 14
Freedom from CAV conditional on survival to discharge by donor and recipient age (transplants: January 2000—June 2017). CAV, cardiac allograft vasculopathy; NS, non-significant.
Figure 15
Figure 15
Freedom from CAV conditional on survival to discharge for recipients aged 11–17 years and donor aged ≥11 years by a history of (a) smoking (transplants: January 2000—June 2017) and (b) alcohol use (transplants: January 2005—June 2017). CAV, cardiac allograft vasculopathy.
Figure 16
Figure 16
Freedom from CAV conditional on survival to discharge for recipients aged 11–17 years and donor aged ≥11 years by a history of (a) cocaine use (transplants: January 2000—June 2017) and (b) other drug use (transplants: January 2000—June 2017). CAV, cardiac allograft vasculopathy.

Similar articles

Cited by

References

    1. Kirk R, Dipchand AI, Davies RR, et al. ISHLT consensus statement on donor organ acceptability and management in pediatric heart transplantation. J Heart Lung Transplant 2020;39:331–41. - PubMed
    1. Rossano JW, Singh TP, Cherikh WS, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric heart transplantation report - 2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019;38:1028–41. - PMC - PubMed
    1. Ford MA, Almond CS, Gauvreau K, et al. Association of graft ischemic time with survival after heart transplant among children in the United States. J Heart Lung Transplant 2011;30:1244–9. - PMC - PubMed
    1. Rossano JW, Cherikh WS, Chambers DC, et al. The Registry of the International Society for Heart and Lung Transplantation: twentieth Pediatric Heart Transplantation Report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant 2017;36:1060–9. - PubMed
    1. Eurostat, Statistics Explained>File: total number of persons killed in road traffic accidents and EU targets, EU-28.png. Available at: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:....

Publication types